病耻感接纳与行动量表的汉化及信效度检验

Chinese version of the Acceptance and Action Questionnaire-Stigma and its reliability and validity

  • 摘要:
    目的 汉化英文版病耻感接纳与行动量表(AAQ-S), 并探讨其在糖尿病患者中的应用效果。
    方法 采用便利抽样法,选取255例糖尿病患者作为研究对象。按照Brislin汉化原则,对量表进行翻译、回译、文化调试和预调查,形成中文版AAQ-S。采用自制一般资料调查表、中文版AAQ-S对糖尿病患者进行问卷调查,并检验量表的信效度。
    结果 中文版AAQ-S的量表内容效度(S-CVI/UA)指数为0.95, 平均水平内容效度(S-CVI/Ave)为0.99。中文版AAQ-S提取心理僵化、心理灵活因子,共21个条目,因子累计方差贡献率为61.020%。中文版AAQ-S的Cronbach′s α为0.958, 重测信度为0.890, Guttman折半信度为0.882。中文版AAQ-S各条目水平的内容效度(I-CVI)指数为0.86~1.00, 总量表的S-CVI/UA为0.95。
    结论 中文版AAQ-S信效度较好,可作为评估糖尿病患者对病耻感接纳程度的评估工具。

     

    Abstract:
    Objective To translate the English version of the Acceptance and Action Questionnaire-Stigma (AAQ-S) into Chinese and explore its application effect in patients with diabetes.
    Methods A convenience sampling method was used to select 255 patients with diabetes as the study subjects. Following the Brislin translation principles, the scale was translated, back-translated, culturally adapted and pre-tested to develop the Chinese version of the AAQ-S. A self-made general data questionnaire and Chinese version of AAQ-S were used to investigate the patients with diabetes, and the reliability and validity of the scale were tested.
    Results The scale level-content validity index/universal agreement (S-CVI/UA) of the Chinese version of the AAQ-S was 0.95, and the average scale-level content validity index (S-CVI/Ave) was 0.99. The Chinese version of AAQ-S extracted psychological rigidity and psychological flexibility factors, with a total of 21 items, and the cumulative variance contribution rate of factors was 61.020%. The Cronbach′s α of the Chinese version of the AAQ-S was 0.958, the test-retest reliability was 0.890, and the Guttman split-half reliability was 0.882. The item-level content validity index (I-CVI) of each item in the Chinese version of the AAQ-S ranged from 0.86 to 1.00, and the S-CVI/UA of the aggregate table was 0.95.
    Conclusion The Chinese version AAQ-S has good reliability and validity, and can be used as an evaluation tool to assess the acceptance of stigma in diabetic patients.

     

/

返回文章
返回